Kerry Clem's most recent trade in Acorda Therapeutics Inc was a trade of 77,300 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 31, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acorda Therapeutics Inc | Kerry Clem | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 77,300 | 77,300 | - | - | Employee Stock Option (right to buy) | |
| Acorda Therapeutics Inc | Kerry Clem | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.40 per share. | 03 Sep 2022 | 1,511 | 10,083 (0%) | 0% | 0.4 | 601 | Common Stock |